| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.05 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.084 | 0.05 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.098 | 0.05 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.15 | 0.05 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.06 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.08 | 0.06 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.077 | 0.06 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.06 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.076 | 0.06 |